Teva committed to stay out of the modafinil markets "because of the substantial value transferred to it by Cephalon," the EC found. • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
